510 related articles for article (PubMed ID: 18199789)
1. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
2. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools.
Chueca N; Garrido C; Alvarez M; Poveda E; de Dios Luna J; Zahonero N; Hernández-Quero J; Soriano V; Maroto C; de Mendoza C; García F
J Med Virol; 2009 May; 81(5):763-7. PubMed ID: 19319937
[TBL] [Abstract][Full Text] [Related]
3. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
[TBL] [Abstract][Full Text] [Related]
4. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
Poveda E; Seclén E; González Mdel M; García F; Chueca N; Aguilera A; Rodríguez JJ; González-Lahoz J; Soriano V
J Antimicrob Chemother; 2009 May; 63(5):1006-10. PubMed ID: 19261623
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
Seclén E; Garrido C; González Mdel M; González-Lahoz J; de Mendoza C; Soriano V; Poveda E
J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
[TBL] [Abstract][Full Text] [Related]
6. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates.
Low AJ; Dong W; Chan D; Sing T; Swanstrom R; Jensen M; Pillai S; Good B; Harrigan PR
AIDS; 2007 Sep; 21(14):F17-24. PubMed ID: 17721088
[TBL] [Abstract][Full Text] [Related]
7. Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use.
Poveda E; Briz V; Roulet V; Del Mar González M; Faudon JL; Skrabal K; Soriano V
AIDS; 2007 Jul; 21(11):1487-90. PubMed ID: 17589199
[TBL] [Abstract][Full Text] [Related]
8. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
9. HIV coreceptor phenotyping in the clinical setting.
Low AJ; Swenson LC; Harrigan PR
AIDS Rev; 2008; 10(3):143-51. PubMed ID: 18820716
[TBL] [Abstract][Full Text] [Related]
10. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates.
Sing T; Low AJ; Beerenwinkel N; Sander O; Cheung PK; Domingues FS; Büch J; Däumer M; Kaiser R; Lengauer T; Harrigan PR
Antivir Ther; 2007; 12(7):1097-106. PubMed ID: 18018768
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
Van Baelen K; Vandenbroucke I; Rondelez E; Van Eygen V; Vermeiren H; Stuyver LJ
J Virol Methods; 2007 Dec; 146(1-2):61-73. PubMed ID: 17640743
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two genotypic algorithms to determine HIV-1 tropism.
Soulié C; Derache A; Aimé C; Marcelin AG; Carcelain G; Simon A; Katlama C; Calvez V
HIV Med; 2008 Jan; 9(1):1-5. PubMed ID: 18199166
[TBL] [Abstract][Full Text] [Related]
13. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
Sato H; Kato K; Takebe Y
Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.
Delgado E; Fernández-García A; Vega Y; Cuevas T; Pinilla M; García V; Sánchez M; González M; Sánchez AM; Thomson MM; Pérez-Álvarez L
J Antimicrob Chemother; 2012 Jan; 67(1):25-31. PubMed ID: 22010208
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.
Braun P; Wiesmann F
Eur J Med Res; 2007 Oct; 12(9):463-72. PubMed ID: 17933728
[TBL] [Abstract][Full Text] [Related]
16. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.
Tscherning C; Alaeus A; Fredriksson R; Björndal A; Deng H; Littman DR; Fenyö EM; Albert J
Virology; 1998 Feb; 241(2):181-8. PubMed ID: 9499793
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
18. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
[TBL] [Abstract][Full Text] [Related]
19. Co-receptor switch during HAART is independent of virological success.
Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
[TBL] [Abstract][Full Text] [Related]
20. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
